CardioDex
Disposable Solution for Closing Arterial Access Sites
Company Overview
Snapshot
Founded in January 2001, CardioDex operated with 1–10 employees, focusing on developing disposable solutions for closing arterial access sites. The company ceased operations in February 2013.
Business overview
CardioDex develops, manufactures, and markets a disposable solution designed for closing arterial access sites following endovascular catheterization procedures. Its core technology expedites arterial closure through hemostasis without using foreign materials like glue, collagen, or sutures, relying instead on familiar balloon inflation/deflation techniques for precise pressure application. The company's products are utilized in both diagnostic and therapeutic markets within the Health Tech & Life Sciences sector, specifically targeting medical devices, diagnostics devices, and medical treatment & therapeutics.
Log in to access full profile ›Company Intelligence Q&A
- What is CardioDex's primary product?
- CardioDex develops a disposable solution for closing arterial access sites after endovascular catheterization procedures, designed to expedite hemostasis without introducing foreign materials into the patient's body.
- When was CardioDex founded?
- CardioDex was founded in January 2001.
- What is the operational status of CardioDex?
- CardioDex ceased to operate in February 2013.
- What markets does CardioDex serve?
- CardioDex's products are used in both diagnostic and therapeutic markets within the healthcare industry.
- How does CardioDex's closure device work?
- The device relies on balloon inflation/deflation techniques to apply selective pressure precisely over the puncture site, avoiding the use of glue, collagen, suturing, or other foreign materials.